Literature DB >> 17669362

Identification of critical residues in nervous necrosis virus B2 for dsRNA-binding and RNAi-inhibiting activity through by bioinformatic analysis and mutagenesis.

Ming-Chang Ou1, Young-Mao Chen, Mei-Fen Jeng, Chiau-Jun Chu, Huey-Lang Yang, Tzong-Yueh Chen.   

Abstract

It is known that the non-structural B2 protein of nervous necrosis virus (NNV) plays an important role in viral replication and can inhibit the RNA interference system of the host cell. Moreover, the mechanism of NNV B2 protein to inhibit RNAi is by sequestration and protection of double strand (ds) RNA. In the flock house virus (FHV), a model alphanodavirus, the structural and mutational analysis of B2 identified that the positively charged Arg54 of the alpha2 helix mediated the dsRNA-binding activity. According to the betanodavirus B2 protein alignment and modeling results, the amino acid sequences and the predicted structure of betanodavirus B2 are different from alphanodaviruses. It was suggested that the four Arg residues of alpha3 helix between amino residues 52-60 of B2 may be involved in dsRNA-binding activity. Thus, this study replaced these four Arg residues with Gln at position 52 (R52Q), 53 (R53Q), 59 (R59Q), and 60 (R60Q) by site-directed mutagenesis method. The dsRNA-binding assays of these B2 mutants demonstrated that mB2(R53Q) and mB2(R60Q) mutants are dsRNA-binding defective. Moreover, we have found mB2(R53Q) and mB2(R60Q) could not antagonize RNAi by using HeLa cell as an RNAi inhibition model. These results suggested that Arg53 and Arg60 of betanodavirus B2 protein may be similar to Arg54 of alphanodavirus FHV B2 protein and are critical for dsRNA binding and RNAi-inhibiting. This study may serve as an example where bioinformatic analysis of related viral genomes may lead to meaningful structural and functional clues for certain viral proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669362     DOI: 10.1016/j.bbrc.2007.07.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Transgenic inhibitors of RNA interference in Drosophila.

Authors:  Yu-ting Chou; Bergin Tam; Fabien Linay; Eric C Lai
Journal:  Fly (Austin)       Date:  2007-11-18       Impact factor: 2.160

2.  Real-time quantitative PCR assay for monitoring of nervous necrosis virus infection in grouper aquaculture.

Authors:  Hsiao-Che Kuo; Ting-Yu Wang; Peng-Peng Chen; Young-Mao Chen; Hui-Ching Chuang; Tzong-Yueh Chen
Journal:  J Clin Microbiol       Date:  2011-01-12       Impact factor: 5.948

3.  Construction of Attenuated Strains for Red-Spotted Grouper Nervous Necrosis Virus (RGNNV) via Reverse Genetic System.

Authors:  Yingying Lei; Yu Xiong; Dagang Tao; Tao Wang; Tianlun Chen; Xufei Du; Gang Cao; Jiagang Tu; Jinxia Dai
Journal:  Viruses       Date:  2022-08-06       Impact factor: 5.818

4.  An automated microfluidic chip system for detection of piscine nodavirus and characterization of its potential carrier in grouper farms.

Authors:  Hsiao-Che Kuo; Ting-Yu Wang; Hao-Hsuan Hsu; Szu-Hsien Lee; Young-Mao Chen; Tieh-Jung Tsai; Ming-Chang Ou; Hsiao-Tung Ku; Gwo-Bin Lee; Tzong-Yueh Chen
Journal:  PLoS One       Date:  2012-08-09       Impact factor: 3.240

5.  Crystal Structures of a Piscine Betanodavirus: Mechanisms of Capsid Assembly and Viral Infection.

Authors:  Nai-Chi Chen; Masato Yoshimura; Hong-Hsiang Guan; Ting-Yu Wang; Yuko Misumi; Chien-Chih Lin; Phimonphan Chuankhayan; Atsushi Nakagawa; Sunney I Chan; Tomitake Tsukihara; Tzong-Yueh Chen; Chun-Jung Chen
Journal:  PLoS Pathog       Date:  2015-10-22       Impact factor: 6.823

6.  s8ORF2 protein of infectious salmon anaemia virus is a RNA-silencing suppressor and interacts with Salmon salar Mov10 (SsMov10) of the host RNAi machinery.

Authors:  Vandana Thukral; Bhavna Varshney; Rimatulhana B Ramly; Sanket S Ponia; Sumona Karjee Mishra; Christel M Olsen; Akhil C Banerjea; Sunil K Mukherjee; Rana Zaidi; Espen Rimstad; Sunil K Lal
Journal:  Virus Genes       Date:  2017-12-07       Impact factor: 2.332

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.